Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 245

Results For "SPE"

5027 News Found

Sonowal and Khandu lay foundation stone for capacity expansion at NEIAFMR
Policy | December 27, 2023

Sonowal and Khandu lay foundation stone for capacity expansion at NEIAFMR

NEIAFMR to be developed as the national hub for folk medicine


AstraZeneca to acquire China's Gracell Biotechnologies for US $1.2 billion
News | December 26, 2023

AstraZeneca to acquire China's Gracell Biotechnologies for US $1.2 billion

Furthering cell therapy ambition across oncology and autoimmune diseases


Eugia's East Windsor facility gets 10 observations from USFDA
Drug Approval | December 25, 2023

Eugia's East Windsor facility gets 10 observations from USFDA

The plant is yet to start commercial operations


Lyndra Therapeutics raises US$101 million in Series E funding
News | December 25, 2023

Lyndra Therapeutics raises US$101 million in Series E funding

Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners


Zydus Lifesciences' API site in Ahmedabad. receives 6 observations from USFDA
Drug Approval | December 23, 2023

Zydus Lifesciences' API site in Ahmedabad. receives 6 observations from USFDA

This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023


USFDA grants priority review for Patritumab Deruxtecan in US for certain patients with EGFR-mutated non-small cell lung cancer
Drug Approval | December 23, 2023

USFDA grants priority review for Patritumab Deruxtecan in US for certain patients with EGFR-mutated non-small cell lung cancer

If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients


Ami Organics inks MoU with a global manufacturer of electrolytes
News | December 22, 2023

Ami Organics inks MoU with a global manufacturer of electrolytes

Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business


JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr
News | December 22, 2023

JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr

JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market


Abbott India MD Vivek Kamath resigns
People | December 22, 2023

Abbott India MD Vivek Kamath resigns

His resignation would be effective from March 18, 2024


Digital transformation key to managing rising organisational healthcare costs in India
Digitisation | December 22, 2023

Digital transformation key to managing rising organisational healthcare costs in India

Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024